| Prev Close | 81.78 |
| Open | 83.53 |
| Day Low/High | 82.44 / 85.77 |
| 52 Wk Low/High | 70.55 / 97.50 |
| Volume | 212.11K |
| Avg Volume | 1.78M |
AmerisourceBergen Corp. (ABC)
86.53
4.80
5.80
NYSE : Distribution Services
| Exchange | NYSE |
| Shares Outstanding | 205.89M |
| Market Cap | 15.51B |
| EPS | 4.10 |
| P/E Ratio | 27.15 |
| Div & Yield | 1.68 (2.15%) |
Latest News
It's as Simple as A-B-C, AmerisourceBergen Has Begun a New Leg Higher
Here's how to play the stock now.
Betting on AmerisourceBergen: As Easy as ABC
Shares of AmerisourceBergen haven't been this cheap since the dark days of 2009.
AmerisourceBergen Stock Is Poised to Retest Key Support Levels
Shares of ABC found buying interest in the $72-$70 area in late December and again in April.
More Mud on Johnson & Johnson?
There's been enough news with the lawsuits around this name to get the emotion back into the stock. Emotion often leads to volatility.
McKesson or Cardinal Health: Which Is a Better Dividend Yield Buy?
Cardinal Health and McKesson have similar business models, but they are very different stocks.
Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter
Straying from these names could land you in quicksand as the 4th quarter begins.
'Death by Amazon' Greatly Exaggerated
Contrarians who bought several "dead men walking" retailers have pocketed big gains by defying conventional wisdom.
CAH Is Among the Best Blue Chip Values
Buy Cardinal Health and give it time for the market to reassess the industry.
Four Cheap 'Dividend Aristocrats' to Buy Now
These stocks are selling at historically low earnings multiples, but have raised their dividends for decades.
Play the Dip on AmerisourceBergen
A low risk stock with a moderate upside makes sense.
The Price Action In AmerisourceBergen Has Been Disappointing Lately
A fresh look at the charts and indicators of ABC seems timely.
Watch: Jim Cramer Reacts to a Potential Walgreens AmerisourceBergen Deal
The Wall Street Journal reported that Walgreens Boots Alliance has contacted AmerisourceBergen about a possible takeover.
Amazon, AmerisourceBergen and Everything Else You Need to Know Before You Trade
With Dow futures pointed south, it looks to be another interesting day on Wall Street. Here's what you need to know.
A Regular Winning Trade Becomes Roadkill in Market Meltdown
Maybe inverse and/or leveraged positions are perverse in nature.
Jim Cramer: The 3 Best Sectors That Lifted the Stock Market
It's hard to understand the magnitude of the change.
The 5 Best 'Dividend Aristocrats' for 2018
The best high-yielding blue chips at discounted prices.
Nvidia Is 1 of 30 Well-Known Stocks That Look Ready to Abruptly Change Direction
These names are showing technical characteristics of either bullish or bearish reversal patterns.
Learning the ABC of a Good Investment
AmerisourceBergen is a high-quality name that offers a ray of value in a pricey market.
Two-Sided Market
An observation:Â Despite being within 1%Â of the all-time high in the S&P Index, this week's feature was a number of investment potholes --relatively large sized individual fundamental disappointments followed by marked stock price drops. Celgene , B...
Positive Signs in Drug Distribution
Blockbuster drugs still need companies to deliver them.
Correction Is Over for AmerisourceBergen
It's time to go long.
Bullish and Bearish Reversals for This Week
Financial names populate the bullish side.
2 Health-Care Stocks Ready to Break Out
Akorn and AmerisourceBergen are both flashing big moves, but in which direction is unclear.
Buy Retail, Pharma, Health-Care on Dips
Demographics will continue to favor health-care and pharmaceutical companies.
This Bullish Setup Is as Easy as ABC
AmerisourceBergen may be headed for a fresh rally leg after breakout to start the year.
Mizuho Analysts Share Their Top Stock Picks for 2017
Apple, Energen and McKesson are among the top stock picks of Mizuho's analysts for 2017.
Uncertainties Making it Difficult for Investors in the Healthcare Sector, says Mizuho Analyst
Since the election, big questions remain about investing in hospital and healthcare stocks, and the group will remain volatile according to Mizuho.
